Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020

SELL
$3.0 - $6.9 $11,139 - $25,619
-3,713 Closed
0 $0
Q1 2020

May 04, 2020

BUY
$2.36 - $9.86 $4,269 - $17,836
1,809 Added 95.01%
3,713 $12,000
Q4 2019

Feb 04, 2020

SELL
$2.69 - $4.92 $298 - $546
-111 Reduced 5.51%
1,904 $12,000
Q3 2019

Nov 12, 2019

BUY
$2.59 - $4.16 $5,218 - $8,382
2,015 New
2,015 $8,000

About APPLIED GENETIC TECHNOLOGIES CORP


  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.